Biocompatibility of a coacervate-based controlled release system for protein delivery to the injured spinal cord

Britta M. Rauck, Tabitha L. Novosat, Martin Oudega, Yadong Wang

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

The efficacy of protein-based therapies for treating injured nervous tissue is limited by the short half-life of free proteins in the body. Affinity-based biomaterial delivery systems provide sustained release of proteins, thereby extending the efficacy of such therapies. Here, we investigated the biocompatibility of a novel coacervate delivery system based on poly(ethylene argininylaspartate diglyceride) (PEAD) and heparin in the damaged spinal cord. We found that the presence of the [PEAD:heparin] coacervate did not affect the macrophage response, glial scarring or nervous tissue loss, which are hallmarks of spinal cord injury. Moreover, the density of axons, including serotonergic axons, at the injury site and the recovery of motor and sensorimotor function were comparable in rats with and without the coacervate. These results revealed the biocompatibility of our delivery system and supported its potential to deliver therapeutic proteins to the injured nervous system.

Original languageEnglish (US)
Pages (from-to)204-211
Number of pages8
JournalActa Biomaterialia
Volume11
Issue numberC
DOIs
StatePublished - 2015

Keywords

  • Biocompatibility
  • Growth factor delivery
  • Nervous tissue loss
  • Sonic hedgehog
  • Spinal cord injury

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering
  • Molecular Biology

Fingerprint Dive into the research topics of 'Biocompatibility of a coacervate-based controlled release system for protein delivery to the injured spinal cord'. Together they form a unique fingerprint.

  • Cite this